Popular Articles

New Drug For Muscular Dystrophy Promises Benefit Without Risk Of Infection
A new drug being studied for the treatment of muscle degenerating diseases has shown promising results. According to a study published in the British Journal of Pharmacology, Debio 025 is as effective as current drugs but, crucially, does not cause unwanted immunosuppressive effects.

Anaphylaxis Canada Launches New Strategy To Help Keep More Than 250,000 Children And Young Adults With Severe Food Allergies Safe
Anaphylaxis Canada is responding to the growing public health challenge of keeping teens and young adults with potentially life-threatening food allergies safe by creating a number of interactive tools including a groundbreaking new website, http://www.whyriskit.ca, an online "Reaction Registry" and radio podcasts. These tools are part of a comprehensive new strategy to help allergic youth manage risky situations by reaching out to them in forums in which they are comfortable.
News of the day
Merck & Co., Inc. And Drugs For Neglected Diseases Initiative Collaborate To Find Treatments For World's Most Neglected Tropical Diseases
On the eve of an international meeting bringing together 200 African researchers to discuss progress on research for neglected tropical diseases (NTD), Merck & Co., Inc. and the not-for-profit Drugs for Neglected Diseases initiative (DNDi) announced a master agreement to support discovery and development of improved treatments for NTDs.
Nutrition

Team Effort Needed To Report On Science, University Of Alberta Study Says

Trust in science is diminishing, according to recent studies, especially in the area of biomedicine, biotech and genetics. University of Alberta researchers Tim Caulfield and Tania Bubela blame it on the complexity of many discoveries and they"re concerned the whole message from the study isn"t getting across to the general public. Caulfield, who is jointly appointed in the Faculty of Law and School of Public Health, and Bubela, also from the School of Public Health, and a group of 22 international experts in health, law, science and communications gathered to discuss ways to ensure the message is complete. They came up with eight recommendations for scientists, universities and media, including: * The wide-ranging factors that contribute to hype and errors must be more explicitly recognized, such as pressure on researchers to make research seem immediately relevant. * Scientists, media and policy makers need to ensure the message is "framed" properly, meaning it is clear why a given scientific issue might be a problem, who or what might be responsible and what should be done. * Researchers should be taught how to communicate their findings clearly with media and policy makers - a lay, non-science audience. Notes: All the recommendations are published in the June edition of Nature Biotechnology. Both are available for interview, please contact me directly. I can also provide you a copy of the study. Quinn Phillips University of Alberta


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):